An upgrade in outlook by a major credit rating agency like Moody's typically reflects a positive view on the company's future ability to meet its financial commitments, which can be seen as a positive signal by investors. This could lead to increased investor confidence in Eli Lilly, potentially driving up the stock price in the short term.